Details of the 1998 Watt Balance Experiment Determining the Planck Constant

by Steiner, Richard, Newell, David, Williams, Edwin
Published 2005

Comparison of two methods of collecting healthcare usage data in chiropractic clinics: patient-report versus documentation in patient files

by Houweling, Taco, Bolton, Jennifer, Newell, David
Published 2014

Population Recovery following Decline in an Endangered Stream-Breeding Frog (Mixophyes fleayi) from Subtropical Australia

by Newell, David Alan, Goldingay, Ross Lindsay, Brooks, Lyndon Owen
Published 2013

Treatment of mesial temporal lobe epilepsy using MRgFUS: laboratory feasibility study

by Monteith, Stephen, Snell, John, Eames, Matt, Newell, David, Gwinn, Ryder
Published 2015

Clinical trial update: treatment of metastatic brain tumors using MRgFUS

by Monteith, Stephen, Newell, David, Vermeulen, Sandra, Cobbs, Charles
Published 2015

Public health engagement: detection of suspicious skin lesions, screening and referral behaviour of UK based chiropractors

by Glithro, Sara, Newell, David, Burrows, Lorna, Hunnisett, Adrian, Cunliffe, Christina
Published 2015

Atypical Presentation of a Sequestered Posterolateral Disc Fragment

by Ajayi, Olaide, Shoakazemi, Alireza, Tubbs, R. Shane, Moisi, Marc, Rostad, Steven, Newell, David W.
Published 2016

The psychometric profile of chiropractic patients in Norway and England: using and comparing the generic versions of the STarT Back 5-item screening tool and the Bournemouth Questi...

by Irgens, Pernille, Lothe, Lise R, Kvammen, Ole Christian, Field, Jonathan, Newell, David
Published 2013

Dural-Based Cavernoma of the Posterior Cranial Fossa Mimicking a Meningioma: A Case Report

by Cruz, Aurora S, Jeyamohan, Shiveindra, Moisi, Marc, Tubbs, R. Shane, Page, Jeni, Chamiraju, Parthasarathi, Tkachenko, Lara, Rostad, Steven, Newell, David W.
Published 2016

Hysteresis and Related Error Mechanisms in the NIST Watt Balance Experiment

by Schwarz, Joshua P., Liu, Ruimin, Newell, David B., Steiner, Richard L., Williams, Edwin R., Smith, Douglas, Erdemir, Ali, Woodford, John
Published 2001

Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma

by Chen, Lindi, Rousseau, Raphaël F., Middleton, Steven A., Nichols, Gwen L., Newell, David R., Lunec, John, Tweddle, Deborah A.
Published 2015

The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice

by Haagensen, Emma J., Thomas, Huw D., Wilson, Ian, Harnor, Suzannah J., Payne, Sara L., Rennison, Tommy, Smith, Kate M., Maxwell, Ross J., Newell, David R.
Published 2013

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation

by Lochhead, Pamela A., Clark, Jonathan, Wang, Lan-Zhen, Gilmour, Lesley, Squires, Matthew, Gilley, Rebecca, Foxton, Caroline, Newell, David R., Wedge, Stephen R., Cook, Simon J.
Published 2016

Herpes Simplex Encephalitis of the Parietal Lobe: A Rare Presentation

by Fisahn, Christian, Tkachenko, Lara, Moisi, Marc, Rostad, Steven, Umeh, Randle, Zwillman, Michael E, Tubbs, R. Shane, Page, Jeni, Newell, David W., Delashaw, Johnny B
Published 2016

Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037

by Haagensen, Emma J., Thomas, Huw D., Schmalix, Wolfgang A., Payne, Andrew C., Kevorkian, Lara, Allen, Rodger A., Bevan, Paul, Maxwell, Ross J., Newell, David R.
Published 2016

Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions† †Electronic supplementary information (ESI) available: Experimental d...

by Blackburn, Tim J., Ahmed, Shafiq, Coxon, Christopher R., Liu, Junfeng, Lu, Xiaohong, Golding, Bernard T., Griffin, Roger J., Hutton, Claire, Newell, David R., Ojo, Stephen, Watson, Anna F., Zaytzev, Andrey, Zhao, Yan, Lunec, John, Hardcastle, Ian R.
Published 2013

Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer

by Coffey, Kelly, Blackburn, Timothy J., Cook, Susan, Golding, Bernard T., Griffin, Roger J., Hardcastle, Ian R., Hewitt, Lorraine, Huberman, Kety, McNeill, Hesta V., Newell, David R., Roche, Celine, Ryan-Munden, Claudia A., Watson, Anna, Robson, Craig N.
Published 2012

Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma

by Alhasan, Sari F, Haugk, Beate, Ogle, Laura F, Beale, Gary S, Long, Anna, Burt, Alastair D, Tiniakos, Dina, Televantou, Despina, Coxon, Fareeda, Newell, David R, Charnley, Richard, Reeves, Helen L
Published 2016

Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer

by Beale, Gary, Haagensen, Emma J, Thomas, Huw D, Wang, Lan-Zhen, Revill, Charlotte H, Payne, Sara L, Golding, Bernard T, Hardcastle, Ian R, Newell, David R, Griffin, Roger J, Cano, Celine
Published 2016

COMPROMISED CDK1 ACTIVITY SENSITIZES BRCA-PROFICIENT CANCERS TO PARP INHIBITION

by Johnson, Neil, Li, Yu-Chen, Walton, Zandra E., Cheng, Katherine A., Li, Danan, Rodig, Scott J., Moreau, Lisa A., Unitt, Christine, Bronson, Roderick T., Thomas, Huw D., Newell, David R., D’Andrea, Alan D., Curtin, Nicola J., Wong, Kwok-Kin, Shapiro, Geoffrey I.
Published 2011